Circulating serum-derived microparticles provide novel proteomic biomarkers of spontaneous preterm birth

American Journal of Perinatology

Volumn 32, Issue 6, 2015, Pages 605-614

  Ezrin, Alan M ^a   Brohman, Brian ^a   Willmot, Jackie ^a   Baxter, Sarah ^b,c   Moore, Keith ^d   Luther, Mike ^e   Fannon, Michael R ^f   Sibai, Baha ^g  

^a NX Prenatal Inc   (United States)

^b David H Murdock Research Institute   (United States)

^c LEVINE CANCER INSTITUTE   (United States)

^d Moore BioAnalysis   (United States)

^e AMRI   (United States)

^f BioIT Solutions Inc   (United States)

^g Division of Maternal Fetal Medicine   (United States)

Author keywords

circulating microparticle; exosome; microvesicle; molecular diagnostic; preterm birth risk; proteomics

Indexed keywords

BIOLOGICAL MARKER;

ADULT; BLOOD; FEMALE; GESTATIONAL AGE; HUMAN; MASS SPECTROMETRY; PREGNANCY; PREMATURITY; PROTEOMICS; RISK FACTOR; SECOND TRIMESTER PREGNANCY; TERM BIRTH;

ADULT; BIOMARKERS; FEMALE; GESTATIONAL AGE; HUMANS; MASS SPECTROMETRY; PREGNANCY; PREGNANCY TRIMESTER, SECOND; PREMATURE BIRTH; PROTEOMICS; RISK FACTORS; TERM BIRTH;

EID: 84937758153     PISSN: 07351631     EISSN: 10988785     Source Type: Journal    
DOI: 10.1055/s-0035-1547322     Document Type: Article

References (26)

1. Howson C. P., Kinney M. V., Lawn J. E. March of Dimes, PMNCH, Save the Children, WHO. Born Too Soon: The Global Action Report on Preterm Birth. Geneva World Health Organization: 2012
2. Conde-Agudelo A., Papageorghiou A. T., Kennedy S. H., Villar J. Novel biomarkers for the prediction of the spontaneous preterm birth phenotype: a systematic review and meta-analysis. BJOG: 2011; 118 9 1042 1054
3. Taylor D. D., Akyol S., Gercel-Taylor C. Pregnancy-associated exosomes and their modulation of T cell signaling. J Immunol: 2006; 176 3 1534 1542
4. Mincheva-Nilsson L., Baranov V. The role of placental exosomes in reproduction. Am J Reprod Immunol: 2010; 63 6 520 533
5. Atay S., Gercel-Taylor C., Suttles J., Mor G., Taylor D. D. Trophoblast-derived exosomes mediate monocyte recruitment and differentiation. Am J Reprod Immunol: 2011; 65 1 65 77
6. Sabapatha A., Gercel-Taylor C., Taylor D. D. Specific isolation of placenta-derived exosomes from the circulation of pregnant women and their immunoregulatory consequences. Am J Reprod Immunol: 2006; 56 5-6 345 355
7. Gercel-Taylor C., Atay S., Tullis R. H., Kesimer M., Taylor D. D. Nanoparticle analysis of circulating cell-derived vesicles in ovarian cancer patients. Anal Biochem: 2012; 428 1 44 53
8. Dragovic R. A., Gardiner C., Brooks A. S., et al. Sizing and phenotyping of cellular vesicles using Nanoparticle Tracking Analysis. Nanomedicine (Lond): 2011; 7 6 780 788
9. Beer L. A., Tang H. Y., Sriswasdi S., Barnhart K. T., Speicher D. W. Systematic discovery of ectopic pregnancy serum biomarkers using 3-D protein profiling coupled with label-free quantitation. J Proteome Res: 2011; 10 3 1126 1138
10. Epple L. M., Griffiths S. G., Dechkovskaia A. M., et al. Medulloblastoma exosome proteomics yield functional roles for extracellular vesicles. PLoS ONE: 2012; 7 7 e42064
11. McLean M., Bisits A., Davies J., et al. Predicting risk of preterm delivery by second-trimester measurement of maternal plasma corticotropin-releasing hormone and alpha-fetoprotein concentrations. Am J Obstet Gynecol: 1999; 181 1 207 215
12. Melamed N., Hiersch L., Meizner I., Bardin R., Wiznitzer A., Yogev Y. Is measurement of cervical length an accurate predictive tool in women with a history of preterm delivery who present with threatened preterm labor? Ultrasound Obstet Gynecol: 2014; 44 6 661 668
13. Stella C. L., Bennett M. R., Devarajan P., et al. Preterm labor biomarker discovery in serum using 3 proteomic profiling methodologies. Am J Obstet Gynecol: 2009; 201 4 387.e1 387.e13
14. Olver C., Vidal M. Proteomic analysis of secreted exosomes. Subcell Biochem: 2007; 43 99 131
15. Simpson R. J., Jensen S. S., Lim J. W. Proteomic profiling of exosomes: current perspectives. Proteomics: 2008; 8 19 4083 4099
16. Pant S., Hilton H., Burczynski M. E. The multifaceted exosome: biogenesis, role in normal and aberrant cellular function, and frontiers for pharmacological and biomarker opportunities. Biochem Pharmacol: 2012; 83 11 1484 1494
17. Théry C. Exosomes: secreted vesicles and intercellular communications. F1000 Biol Rep: 2011; 3 15
18. Esplin M. S., Merrell K., Goldenberg R., et al. Eunice Kennedy Shriver National Institute of Child Health and Human Development Maternal-Fetal Medicine Units Network. Proteomic identification of serum peptides predicting subsequent spontaneous preterm birth. Am J Obstet Gynecol: 2011; 204 5 391.e1 391.e8
19. Saunders R. D., Nakajima S. T., Rai S. N., Pan J., Gercel-Taylor C., Taylor D. D. Alterations in antibody subclass immune reactivity to trophoblast-derived fetal fibronectin and α2-macroglobulin in women with recurrent pregnancy loss. Am J Reprod Immunol: 2012; 68 5 438 449
20. Christiaens I., Zaragoza D. B., Guilbert L., Robertson S. A., Mitchell B. F., Olson D. M. Inflammatory processes in preterm and term parturition. J Reprod Immunol: 2008; 79 1 50 57
21. Lindström T. M., Bennett P. R. The role of nuclear factor kappa B in human labour. Reproduction: 2005; 130 5 569 581
22. Hadfield K. A., McCracken S. A., Ashton A. W., Nguyen T. G., Morris J. M. Regulated suppression of NF-κB throughout pregnancy maintains a favourable cytokine environment necessary for pregnancy success. J Reprod Immunol: 2011; 89 1 1 9
23. MacIntyre D. A., Sykes L., Teoh T. G., Bennett P. R. Prevention of preterm labour via the modulation of inflammatory pathways. J Matern Fetal Neonatal Med: 2012; 25 01 17 20
24. Lee Y., Sooranna S. R., Terzidou V., et al. Interactions between inflammatory signals and the progesterone receptor in regulating gene expression in pregnant human uterine myocytes. J Cell Mol Med: 2012; 16 10 2487 2503
25. Tang H. Y., Beer L. A., Barnhart K. T., Speicher D. W. Rapid verification of candidate serological biomarkers using gel-based, label-free multiple reaction monitoring. J Proteome Res: 2011; 10 9 4005 4017
26. Regnier F. E., Skates S. J., Mesri M., et al. Protein-based multiplex assays: mock presubmissions to the US Food and Drug Administration. Clin Chem: 2010; 56 2 165 171